UTC Investment Co.
VC Fund
Seoul, South Korea
UTC Investment Co. is a VC fund in Seoul focused on Biotechnology and Health Care. Since its incorporation in 1988, UTC Investment has been implementing and developing private equity investments with deep roots in buyout area, diversified human resources, and an impressive track record as a leading global investment firm.
- Total investments:
- 125
- Last investment:
- Lead investor:
- 11%
Last updated:
For AI agents: llms.txt
Industries UTC Investment Co. invests in
Stages UTC Investment Co. invests in
Countries UTC Investment Co. invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
2 more contacts available
Round size
- Series A
- $2.3M–$13M
- Series B
- $4.9M–$21M
Investment Focus
Industry
- Biotechnology 29 (23%)
- Health Care 21 (17%)
- Medical 17 (14%)
- Information Technology 15 (12%)
- Pharmaceutical 14 (11%)
Stage
- Funding Round 36 (29%)
- Series A 28 (22%)
- Series B 22 (18%)
- Seed 17 (14%)
- Series C 10 (8%)
Country
- South Korea 98 (78%)
- United States 5 (4%)
- Japan 2 (2%)
- France 1 (1%)
- North Korea 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Ji-young Kim
Manager
|
Manager | Total investments: 1 | Find email | |
Kanghak Lee
Managing Director
|
Managing Director | Total investments: 1 | Find email | |
Se-young Kim
CEO
|
CEO | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
CanLab
|
CanLab is a developer of AI sensors that focuses on creating optical and thermal cameras, as well as real-time image processing platforms for ground, aerial, and marine mobility. Its product offerings include the Vision Camera, Edge AI Platform, Equipment for Thermal Cameras, and Automotive Camera MES. | $4.3M / Series A / Aug 11, 2025 | |
AD System
|
AD System focuses on the development, manufacturing, sales and repairing of drones and other unmanned aerial vehicles. | $2.2M / Seed / Jun 19, 2025 | |
Beamworks
|
Beamworks is a research-centered company in medical imaging and conversational AI, that enables expert-level cancer diagnosis anywhere in the world and providing reliable medical consultations at any time. The company's platform utilizes an on-device AI system that processes ultrasound data in real-time without the need for serverconnectivity, achieving detection sensitivity and differential diagnosis performance, enabling healthcare providers to offer precise and timely diagnostics and improve patient outcomes, and reduce unnecessary procedures. | $10.9M / Venture - Series Unknown / Jun 02, 2025 | |
Pebble Square
|
Pebble Square's new Processing-In-Memory (PIM) architecture is a significant advancement for AI performance and power efficiency. | Mar 10, 2025 | |
|
Pebble Square
|
Pebble Square's new Processing-In-Memory (PIM) architecture is a significant advancement for AI performance and power efficiency. | $1.4M / Seed / Mar 10, 2025 | |
Cureverse
|
Cureverse operates a pharmaceutical research and development company for the treatment of encephalopathy and oncology diseases. The company focuses on creating remedies for challenging brain conditions like dementia, thereby assisting healthcare professionals in enhancing human well-being and overall quality of life. | $17.1M / Series B / Jan 17, 2025 | |
WASHSWAT
|
Washswat is a laundry service that washes and dries the laundry that is operated by specialized facilities and personnel. They innovate the market with IT technology. Laundromat started in Gangnam with the highest number of high-end cleaners in 2015 and walked step by step silently. In order to grow in the right direction even though it is alittle slower than others, they did not rush to expand the region. Now it is Korea's No. 1 mobile laundry special service at the King of Seoul, Seongnam, Hanam, Goyang, Gwangmyeong, Yongin, Suwon, Anyang, and Gwacheon. | $5M / Series C / Nov 27, 2024 | |
Solmedix
|
Solmedix is a medical device company that develops and commercializes surgical and healthcare technologies. It focuses on creating disposable medical devices and treatment systems, and uses its MOSAIC platform to evaluate, develop, and bring new medical ideas. | Nov 13, 2024 | |
|
Solmedix
|
Solmedix is a medical device company that develops and commercializes surgical and healthcare technologies. It focuses on creating disposable medical devices and treatment systems, and uses its MOSAIC platform to evaluate, develop, and bring new medical ideas. | $1.1M / Series B / Nov 13, 2024 | |
Monitor
|
Lucas develops a system to detect, measure, categorize and track nodules in the screening CT images. | $5.3M / Series B / Oct 02, 2024 | |
| See all 125 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does UTC Investment Co. invest in?
UTC Investment Co. invests primarily in Biotechnology, Health Care and Medical startups, most often at Funding Round and Series A stage. Most of the 125 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is UTC Investment Co.'s check size?
UTC Investment Co. typically joins rounds of $2.3M–$13M at Series A and $4.9M–$21M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds UTC Investment Co. participates in.
How do I contact UTC Investment Co.?
Public channels for UTC Investment Co. include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at UTC Investment Co.?
The team at UTC Investment Co. includes Ji-young Kim (Manager), Kanghak Lee (Managing Director) and Se-young Kim (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
